Literature DB >> 33033902

Transcription factor Kruppel-like factor 5 positively regulates the expression of AarF domain containing kinase 4.

Xi Chen1, Shuang Liu1, Jiahe Chen1, Xinyu Wang1, Guoping Zhou2.   

Abstract

AarF domain containing kinase 4 (ADCK4) is identified as a candidate gene associated with hereditary nephrotic syndrome (NS). Kruppel-like factor 5 (KLF5) is reported to promote podocyte survival by blocking the ERK/p38 MAPK pathways. Both ADCK4 and KLF5 are involved in the occurrence and development of podocyte disease, but their interaction remains unclear. Firstly, we found that the mRNA levels of ADCK4 and KLF5 decreased in NS patients, and both levels showed an obvious linear relationship. Secondly, we cloned the ADCK4 promoter region and examined its promoter activity in Hela, A549, and HEK 293 cell lines. Deletion analysis showed that the region - 116/- 4 relative to the transcriptional start site (TSS) was the core region of ADCK4 promoter. Thirdly, mutation analysis showed that putative binding sites for KLF5 contributed to the ADCK4 promoter activity. In HEK293 cells, we found that KLF5 upregulated the mRNA and protein levels of ADCK4. Finally, our chromatin immunoprecipitation assay found that KLF5 could bind to the specific region of ADCK4 promoter. These results showed that KLF5 can positively regulate the transcriptional activity of ADCK4.

Entities:  

Keywords:  AarF domain containing kinase 4; Kruppel-like factor 5; Nephrotic syndrome; Promoter; Transcriptional regulation

Mesh:

Substances:

Year:  2020        PMID: 33033902     DOI: 10.1007/s11033-020-05882-w

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  25 in total

1.  Focal segmental glomerulosclerosis and medullary nephrocalcinosis in children with ADCK4 mutations.

Authors:  Eujin Park; Hee Gyung Kang; Young Hun Choi; Kyoung Bun Lee; Kyung Chul Moon; Hyeon Joo Jeong; Michio Nagata; Hae Il Cheong
Journal:  Pediatr Nephrol       Date:  2017-04-12       Impact factor: 3.714

2.  Early coenzyme Q10 supplementation in primary coenzyme Q10 deficiency.

Authors:  Giovanni Montini; Cristina Malaventura; Leonardo Salviati
Journal:  N Engl J Med       Date:  2008-06-26       Impact factor: 91.245

3.  Follow-up results of patients with ADCK4 mutations and the efficacy of CoQ10 treatment.

Authors:  Mustafa Atmaca; Bora Gulhan; Emine Korkmaz; Mihriban Inozu; Oguz Soylemezoglu; Cengiz Candan; Aysun Karabay Bayazıt; Ahmet Midhat Elmacı; Gonul Parmaksiz; Ali Duzova; Nesrin Besbas; Rezan Topaloglu; Fatih Ozaltin
Journal:  Pediatr Nephrol       Date:  2017-03-24       Impact factor: 3.714

4.  ADCK4-Associated Glomerulopathy Causes Adolescence-Onset FSGS.

Authors:  Emine Korkmaz; Beata S Lipska-Ziętkiewicz; Olivia Boyer; Olivier Gribouval; Cecile Fourrage; Mansoureh Tabatabaei; Sven Schnaidt; Safak Gucer; Figen Kaymaz; Mustafa Arici; Ayhan Dinckan; Sevgi Mir; Aysun K Bayazit; Sevinc Emre; Ayse Balat; Lesley Rees; Rukshana Shroff; Carsten Bergmann; Chebl Mourani; Corinne Antignac; Fatih Ozaltin; Franz Schaefer
Journal:  J Am Soc Nephrol       Date:  2015-05-12       Impact factor: 10.121

5.  Recurrent and functional regulatory mutations in breast cancer.

Authors:  Esther Rheinbay; Prasanna Parasuraman; Jonna Grimsby; Grace Tiao; Jesse M Engreitz; Jaegil Kim; Michael S Lawrence; Amaro Taylor-Weiner; Sergio Rodriguez-Cuevas; Mara Rosenberg; Julian Hess; Chip Stewart; Yosef E Maruvka; Petar Stojanov; Maria L Cortes; Sara Seepo; Carrie Cibulskis; Adam Tracy; Trevor J Pugh; Jesse Lee; Zongli Zheng; Leif W Ellisen; A John Iafrate; Jesse S Boehm; Stacey B Gabriel; Matthew Meyerson; Todd R Golub; Jose Baselga; Alfredo Hidalgo-Miranda; Toshi Shioda; Andre Bernards; Eric S Lander; Gad Getz
Journal:  Nature       Date:  2017-06-28       Impact factor: 49.962

6.  Risk SNP-Mediated Promoter-Enhancer Switching Drives Prostate Cancer through lncRNA PCAT19.

Authors:  Junjie Tony Hua; Musaddeque Ahmed; Haiyang Guo; Yuzhe Zhang; Sujun Chen; Fraser Soares; Jennifer Lu; Stanley Zhou; Miranda Wang; Hui Li; Nicholas B Larson; Shannon K McDonnell; Parasvi S Patel; Yi Liang; Cindy Q Yao; Theodorus van der Kwast; Mathieu Lupien; Felix Y Feng; Amina Zoubeidi; Ming-Sound Tsao; Stephen N Thibodeau; Paul C Boutros; Housheng Hansen He
Journal:  Cell       Date:  2018-07-19       Impact factor: 41.582

7.  A novel ADCK4 mutation in a Chinese family with ADCK4-Associated glomerulopathy.

Authors:  Jing Yang; Yuan Yang; Zhangxue Hu
Journal:  Biochem Biophys Res Commun       Date:  2018-10-21       Impact factor: 3.575

Review 8.  Treatment of steroid-resistant nephrotic syndrome in the genomic era.

Authors:  Adam R Bensimhon; Anna E Williams; Rasheed A Gbadegesin
Journal:  Pediatr Nephrol       Date:  2018-10-02       Impact factor: 3.714

9.  ADCK4 "reenergizes" nephrotic syndrome.

Authors:  Laura Malaga-Dieguez; Katalin Susztak
Journal:  J Clin Invest       Date:  2013-11-25       Impact factor: 14.808

10.  ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption.

Authors:  Shazia Ashraf; Heon Yung Gee; Stephanie Woerner; Letian X Xie; Virginia Vega-Warner; Svjetlana Lovric; Humphrey Fang; Xuewen Song; Daniel C Cattran; Carmen Avila-Casado; Andrew D Paterson; Patrick Nitschké; Christine Bole-Feysot; Pierre Cochat; Julian Esteve-Rudd; Birgit Haberberger; Susan J Allen; Weibin Zhou; Rannar Airik; Edgar A Otto; Moumita Barua; Mohamed H Al-Hamed; Jameela A Kari; Jonathan Evans; Agnieszka Bierzynska; Moin A Saleem; Detlef Böckenhauer; Robert Kleta; Sherif El Desoky; Duygu O Hacihamdioglu; Faysal Gok; Joseph Washburn; Roger C Wiggins; Murim Choi; Richard P Lifton; Shawn Levy; Zhe Han; Leonardo Salviati; Holger Prokisch; David S Williams; Martin Pollak; Catherine F Clarke; York Pei; Corinne Antignac; Friedhelm Hildebrandt
Journal:  J Clin Invest       Date:  2013-11-25       Impact factor: 14.808

View more
  2 in total

Review 1.  Roles of Krüppel-like factor 5 in kidney disease.

Authors:  Jia Li; Liang Liu; Wen-Qian Zhou; Lu Cai; Zhong-Gao Xu; Madhavi J Rane
Journal:  J Cell Mol Med       Date:  2021-02-01       Impact factor: 5.310

Review 2.  Recent Advances in Diabetic Kidney Diseases: From Kidney Injury to Kidney Fibrosis.

Authors:  Peir-Haur Hung; Yung-Chien Hsu; Tsung-Hsien Chen; Chun-Liang Lin
Journal:  Int J Mol Sci       Date:  2021-11-01       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.